BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Chronic myeloid leukemia (CML) is a hematological malignancy that results when HSCs acquire the fusion oncogene BCR-ABL, leading to constitutive activation of the ABL tyrosine kinase.